Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation
Phase 2
Completed
- Conditions
- Ejaculation
- Registration Number
- NCT00219583
- Lead Sponsor
- Pfizer
- Brief Summary
Assessment of efficacy and safety UK-390,957.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 460
Inclusion Criteria
- Premature ejaculation as defined by DSM-IV
Read More
Exclusion Criteria
- History of erectile dysfunction
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Assessment of efficacy and safety
- Secondary Outcome Measures
Name Time Method Assessment of quality of sexual life
Trial Locations
- Locations (1)
Pfizer Investigational Site
🇹🇷Balcova, Izmir, Turkey